Article
A regional analysis of epidermal growth factor receptor (EGFR) mutated lung cancer for HSE South.
Irish journal of medical science - 1 Nov 2017
Kelly D, Mc Sorley L, O'Shea E, Mc Carthy E, Bowe S, Brady C, Sui J, Dawod M A, O'Brien O, Graham D, McCarthy J, Burke L, Power D, O'Reilly S, Bambury R M, Mahony D O
Abstract excerpt
BACKGROUND: EGFR mutated lung cancer represents a subgroup with distinct clinical presentations, prognosis, and management requirements. We investigated the survival, prognostic factors, and real-world treatment of NSCLC patients with EGFR mutation in clinical practice. METHODS: A retrospective review of all specimens sent for EGFR analysis from December 2009 to September 2015 was performed. Patient demographics,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
